Swamy Vijayan

Swamy Vijayan is the CEO and cofounder of Zafrens, a San Diego biotech reinventing drug discovery by shrinking a 96-well plate down to 200,000 microwells that image and sequence single cells at once. A physicist by training who admits he was driven less by a love of biology than by dissatisfaction with theoretical physics, he is a serial founder whose previous company Omniome sold to Pacific Biosciences for up to $800 million. His stated goal is not a quick exit but a foundation for smart people to do important things for the next 100 years.